BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Genocea Biosciences, Inc. (“Genocea” or the “Company”) (NASDAQ: GNCA) investors concerning the Company and its officers’ possible violations of federal securities laws.
On September 25, 2017 Genocea disclosed that it was halting spending and activities on GEN-003 and exploring strategic alternatives for the drug. Genocea also announced that it was cutting 40% of its workforce.
On this news, Genocea’s share price fell $4.08, or 76.5%, to close at $1.25 on September 26, 2017, thereby damaging investors.
If you purchased Genocea securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to email@example.com, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.